SupplementsExercise

Long-term wearable monitoring reveals that sustained behavior change leading to substantial weight loss is associated with favorable cardiometabolic adaptations in a highly motivated young adult male.

In a single-participant case study, a young adult male achieved a 27.8% reduction in body weight over three years, accompanied by improvements in resting heart rate (69.5 to 53.6 bpm), heart rate variability (40.6 to 75.5 ms), and clinical biomarkers such as fasting glucose (102 to 82 mg/dL) and triglycerides (134 to 74 mg/dL). Post-weight-loss VO2max (46.9 ml/kg/min) and body fat (21.6%) were favorable compared to norms. The study demonstrates the potential of continuous wearable monitoring to capture behavior-driven cardiometabolic changes in real-world settings.

Last updated: Aug 26, 2026โ€ข0 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score32/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. From couch to Ironman 70.3: A three-year case study of weight loss and cardiometabolic adaptation revealed through continuous wearable monitoring.

observational

Montoye AHK, Grosicki GJ, Babcock MC, Fielding F, von Hippel W, Chapman C, Henderson D, Lee VH, Holmes KE ยท Journal of sports sciences (2026)

Participants: N/A
Duration: 3 years (1,146 days)
Intervention: Sustained behavior change including increased physical activity (from 12.0 to 38.6 hours/month) and weight loss; no specific dietary intervention was recorded.
Outcome: Body weight, resting heart rate, heart rate variability (RMSSD), HRV coefficient of variation, physical activity, clinical biomarkers (fasting glucose, triglycerides, LDL, HDL), VO2max, and body composition (DEXA).
Effect Size: N/A
Population: A single highly motivated young adult male (age not specified) with initial body weight of 122.3 kg.

Result:

Mechanism Graph

Increased physical activity and sustained behavior change
โ†“
Reduction in body weight (27.8%)
โ†“
Improvement in autonomic function (lower RHR, higher HRV)
โ†“
Improvement in metabolic biomarkers (glucose, lipids)
โ†“
Result: Favorable cardiometabolic adaptation and improved fitness

Limitations

  • โš Single-participant case study, limiting generalizability
  • โš Dietary intake was not recorded, so the contribution of diet to weight loss and cardiometabolic changes cannot be assessed
  • โš No control group or statistical inference
  • โš Post-weight-loss VO2max and body composition were assessed only after weight loss, not at baseline

Frequently Asked Questions

What were the key improvements in cardiometabolic health in this case study?โ–ผ

The participant experienced reductions in resting heart rate (from 69.5 to 53.6 bpm), improvements in heart rate variability (from 40.6 to 75.5 ms), and favorable changes in fasting glucose (102 to 82 mg/dL), triglycerides (134 to 74 mg/dL), LDL (89 to 72 mg/dL), and HDL (33 to 42 mg/dL).

How much weight was lost and over what period?โ–ผ

The participant lost 27.8% of his body weight, decreasing from 122.3 kg to 88.3 kg over three years (May 2022 to May 2025).

What role did wearable monitoring play in this study?โ–ผ

Wearable devices provided continuous daily data on resting heart rate, heart rate variability, sleep, and physical activity over 1,146 days, allowing detailed tracking of physiological changes during the weight loss journey.

What was the participant's fitness level after weight loss?โ–ผ

Post-weight-loss VO2max was 46.9 ml/kg/min and body fat was 21.6%, both comparing favorably with age- and sex-based norms. The participant also completed an Ironman 70.3 triathlon.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Montoye AHK, Grosicki GJ, Babcock MC, Fielding F, von Hippel W, Chapman C, Henderson D, Lee VH, Holmes KE. "From couch to Ironman 70.3: A three-year case study of weight loss and cardiometabolic adaptation revealed through continuous wearable monitoring.." Journal of sports sciences, 2026. PMID: 42633559 DOI: 10.1080/02640414.2026.2721858
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.